Quantcast

Latest Fludeoxyglucose Stories

2009-12-08 11:25:00

NEW YORK, Dec. 8 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Radiopharmaceuticals - A US and European Market Analysis http://www.reportlinker.com/p0164273/Radiopharmaceuticals---A-US-and-European-Market-Analysis.html The market for radiopharmaceuticals continues to gain momentum with heightened interest in therapeutic efficiency, acceptance and utilization of nuclear medicine equipment, as well as development of newer...

2009-11-25 14:14:33

A recent study shows that 95 percent of radiation oncologists use advanced imaging techniques such as positron emission tomography (FDG-PET), magnetic resonance imaging (MRI), and 4-dimensional computed tomography (4DCT) for target delineation (to locate the tumor and other areas at risk for having cancer), according to an article in the December issue of the Journal of the American College of Radiology, (JACR, www.jacr.org). In defining the target, the radiation oncologist draws upon a...

2009-10-29 12:34:00

PARK CITY, Utah, Oct. 29 /PRNewswire/ -- Researchers at Thomas Jefferson University in Philadelphia, PA, supported in part by NuView Life Sciences, have published an article in the Journal of Nuclear Medicine reporting preclinical results of a novel PET biomarker designed to selectively detect malignant breast tumors[1]. "All tumors detected with the new biomarker were malignant and expressed the targeted VPAC1 receptors located on the plasma membrane of the tumor cells." These results...

2009-10-01 11:04:48

Research published in the October 2009 issue of the Journal of Thoracic Oncology has found an effective combination of positron emission tomography (PET)/computed tomography (CT) (PET/CT) tests to diagnose lung cancer in a "fast-tracked" outpatient setting. This novel approach to the diagnosis of lung cancer demonstrated a high level of sensitivity (97%) and accuracy (82%). The fast track model tests patients for lung cancer over the course of one day and could expedite identification and...

2009-09-10 08:54:00

NEW YORK, Sept. 10 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. US and European Radiopharmaceuticals Market http://www.reportlinker.com/p0109914/US-and-European-Radiopharmaceuticals-Market.html This report analyzes the US and the European markets for Radiopharmaceuticals in Millions of US$. The major product segments analyzed are Diagnostic Radiopharmaceuticals, and Therapeutic Radiopharmaceuticals. Annual forecasts are...

2009-08-24 09:53:00

WARRENDALE, Pa., Aug. 24 /PRNewswire/ -- MEDRAD, Inc. has signed a research agreement with the University of South Florida (USF) to study the impact of automated Fluoro-deoxy-glucose (FDG) administration on the workflow for Positron Emission Tomography (PET) imaging procedures. Clinicians at Moffitt Cancer Center in Tampa, Florida will utilize MEDRAD's Intego(TM) PET Infusion System to measure and infuse patient-specific FDG doses while industrial engineers from USF gather and analyze...

2009-08-03 10:05:05

A new study published in the August issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) is an important tool for depicting the extent of neuroblastoma in some patients, particularly for those in the early stages of the disease. Neuroblastoma accounts for six to ten percent of all childhood cancers in the United States and 15 percent of cancer deaths in children. Accurately identifying where in the body the disease is located and whether it is spreading is...

2009-08-03 07:30:00

DUBLIN, Ohio, Aug. 3 /PRNewswire-FirstCall/ -- Cardinal Health today announced it has agreed to acquire the assets of privately held Biotech, an operator of Positron Emission Tomography (PET) cyclotrons and nuclear pharmacies in the Southwestern United States. Cardinal Health owns and operates a network of nearly 160 nuclear pharmacies and operates 26 cyclotron-based PET radiopharmaceutical manufacturing facilities. These facilities are registered with the Food and Drug Administration...

2009-07-13 07:45:00

RARITAN, N.J., July 13 /PRNewswire/ -- Measuring the change in circulating tumor cell (CTC) count can accurately predict the prognosis and survival in patients with metastatic breast cancer (MBC), according to a newly published report in the July 10 issue of the Journal of Clinical Oncology. The retrospective study compared how well CTCs and a more sensitive than conventional modality, fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT), predicted survival in...

9a667d701bf8f1571949e44f18fca8a31
2009-06-15 16:30:00

Tumor metabolism discovery opens new detection and treatment possibilities for rare form of colon cancerPeople who suffer from Peutz-Jeghers syndrome, a rare inherited cancer syndrome, develop gastrointestinal polyps and are predisposed to colon cancer and other tumor types. Carefully tracing the cellular chain-of-command that links nutrient intake to cell growth (and which is interrupted in Peutz-Jeghers syndrome), allowed researchers at the Salk Institute for Biological Studies to exploit...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.